A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism (Q28585467)

GOA release 2020-03-11

5

Eva Csizmadia

1 reference

31 January 2017

1

Christopher R. Longo

1 reference

31 January 2017

Virendra I. Patel

2

1 reference

31 January 2017

Gautam V. Shrikhande

3

1 reference

31 January 2017

Salvatore T. Scali

4

1 reference

31 January 2017

Soizic Daniel

6

1 reference

31 January 2017

David W. Sun

7

1 reference

31 January 2017

Shane T. Grey

8

1 reference

31 January 2017

Maria B. Arvelo

9

1 reference

31 January 2017

Christiane Ferran

10

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

31 January 2017

1 reference

31 January 2017

42

1 reference

31 January 2017

1

1 reference

31 January 2017

156–164

1 reference

31 January 2017

1 reference

7 January 2021

Fulminant hepatic failure. Presumable contribution to halothane

1 reference

7 January 2021

1 reference

7 January 2021

1 reference

7 January 2021

A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism

1 reference

7 January 2021

A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets

1 reference

7 January 2021

A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis

1 reference

7 January 2021

A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activation

1 reference

7 January 2021

Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice

1 reference

7 January 2021

Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection.

1 reference

7 January 2021

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

1 reference

7 January 2021

Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration

1 reference

7 January 2021

A model to predict survival in patients with end-stage liver disease

1 reference

7 January 2021

1 reference

7 January 2021

Targets of the cyclin-dependent kinase Cdk1

1 reference

7 January 2021

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor

1 reference

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

7 January 2021

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene

1 reference

7 January 2021

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration

1 reference

7 January 2021

NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases

1 reference

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

7 January 2021

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B

1 reference

7 January 2021

Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.

1 reference

7 January 2021

Interleukin 6 is important for survival after partial hepatectomy in mice

1 reference

7 January 2021

Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury.

1 reference

7 January 2021

Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms

1 reference

7 January 2021

In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats

1 reference

7 January 2021

In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway.

1 reference

7 January 2021

Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration

1 reference

7 January 2021

Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver

1 reference

7 January 2021

Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration

1 reference

7 January 2021

The Cdk inhibitor p21 is required for necrosis, but it inhibits apoptosis following toxin-induced liver injury

1 reference

7 January 2021

Regenerating livers of old rats contain high levels of C/EBPalpha that correlate with altered expression of cell cycle associated proteins

1 reference

7 January 2021

CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy

1 reference

7 January 2021

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling

1 reference

7 January 2021

Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased

1 reference

7 January 2021

Complete reconstitution of mouse liver with xenogeneic hepatocytes

1 reference

7 January 2021

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

1 reference

7 January 2021

MINIMUM GRAFT VOLUME FOR SUCCESSFUL ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE

1 reference

7 January 2021

Long-term results of pediatric liver transplantation: an analysis of 569 transplants

1 reference

7 January 2021